Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that its Investigational New Drug (IND) application for SKB105 (also known as CR-003), an ...
(MENAFN- GlobeNewsWire - Nasdaq) Needle-Free Growth Hormone Support via Telehealth - Platform Analysis Compares Compounded Prescription Tablets vs. Injectable Format as Consumer Search Volume for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results